Sharon Boast

2.9k total citations
25 papers, 2.4k citations indexed

About

Sharon Boast is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Sharon Boast has authored 25 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Genetics and 7 papers in Hematology. Recurrent topics in Sharon Boast's work include Chronic Myeloid Leukemia Treatments (7 papers), CRISPR and Genetic Engineering (4 papers) and Animal Genetics and Reproduction (4 papers). Sharon Boast is often cited by papers focused on Chronic Myeloid Leukemia Treatments (7 papers), CRISPR and Genetic Engineering (4 papers) and Animal Genetics and Reproduction (4 papers). Sharon Boast collaborates with scholars based in United States, United Kingdom and Singapore. Sharon Boast's co-authors include Stephen P. Goff, Jeff Hardin, Ihor R. Lemischka, Francesco Blasi, Pasquale Verde, Pamela L. Schwartzberg, Alan M. Stall, Claudio D. Stern, H. Shelton Earp and Margaret L. Harbison and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Sharon Boast

25 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sharon Boast United States 17 1.2k 705 691 327 309 25 2.4k
Seiji Sakano Japan 25 1.6k 1.3× 670 1.0× 412 0.6× 274 0.8× 319 1.0× 37 2.7k
Cheryl A. Whitlock United States 17 760 0.6× 894 1.3× 653 0.9× 304 0.9× 338 1.1× 19 2.0k
Hayley S. Ramshaw Australia 28 1.1k 0.9× 1.1k 1.6× 950 1.4× 314 1.0× 752 2.4× 54 2.8k
Leonid Eshkind Germany 18 1.6k 1.3× 665 0.9× 846 1.2× 231 0.7× 353 1.1× 31 2.9k
M Klemsz United States 13 1.4k 1.2× 1.3k 1.8× 384 0.6× 201 0.6× 575 1.9× 17 2.8k
R V Lebo United States 23 1.1k 0.9× 221 0.3× 515 0.7× 415 1.3× 204 0.7× 40 2.2k
Emmanuelle Six France 23 1.4k 1.2× 464 0.7× 266 0.4× 324 1.0× 358 1.2× 35 2.0k
Fred Sablitzky United Kingdom 30 2.0k 1.7× 1.2k 1.7× 235 0.3× 492 1.5× 385 1.2× 48 3.4k
K Nocka United States 12 865 0.7× 831 1.2× 419 0.6× 257 0.8× 211 0.7× 15 2.0k
Tamara Byk Israel 13 934 0.8× 877 1.2× 928 1.3× 231 0.7× 946 3.1× 15 2.6k

Countries citing papers authored by Sharon Boast

Since Specialization
Citations

This map shows the geographic impact of Sharon Boast's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Boast with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Boast more than expected).

Fields of papers citing papers by Sharon Boast

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Boast. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Boast. The network helps show where Sharon Boast may publish in the future.

Co-authorship network of co-authors of Sharon Boast

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Boast. A scholar is included among the top collaborators of Sharon Boast based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Boast. Sharon Boast is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jing, Peiquan Zhao, Huijuan Liu, et al.. (2015). Palmitoyl acyltransferase Aph2 in cardiac function and the development of cardiomyopathy. Proceedings of the National Academy of Sciences. 112(51). 15666–15671. 31 indexed citations
2.
Oliveira, Nidia M. M., et al.. (2014). Transcriptome analysis of chicken ES, blastodermal and germ cells reveals that chick ES cells are equivalent to mouse ES cells rather than EpiSC. Stem Cell Research. 14(1). 54–67. 44 indexed citations
3.
Liu, Huijuan, Wai Fook Leong, Lili Li, et al.. (2012). c-Abl promotes osteoblast expansion by differentially regulating canonical and non-canonical BMP pathways and p16INK4a expression. Nature Cell Biology. 14(7). 727–737. 50 indexed citations
4.
Boast, Sharon & Claudio D. Stern. (2012). Simple methods for generating neural, bone and endodermal cell types from chick embryonic stem cells. Stem Cell Research. 10(1). 20–28. 10 indexed citations
5.
Papanayotou, Costis, Anne Mey, Anne‐Marie Birot, et al.. (2008). A Mechanism Regulating the Onset of Sox2 Expression in the Embryonic Neural Plate. PLoS Biology. 6(1). e2–e2. 144 indexed citations
6.
Li, Baojie, Xueying Wang, Yuanyu Hu, et al.. (2004). Distinct roles of c-Abl and Atm in oxidative stress response are mediated by protein kinase C δ. Genes & Development. 18(15). 1824–1837. 92 indexed citations
7.
Li, Baojie, Sharon Boast, Kenia de los Santos, et al.. (2000). Mice deficient in Abl are osteoporotic and have defects in osteoblast maturation. Nature Genetics. 24(3). 304–308. 124 indexed citations
8.
Lu, Qingxian, Qing Zhang, Todd D. Camenisch, et al.. (1999). Tyro-3 family receptors are essential regulators of mammalian spermatogenesis. Nature. 398(6729). 723–728. 414 indexed citations
9.
Hardin, Jeff, Sharon Boast, Pamela L. Schwartzberg, et al.. (1996). Abnormal Peripheral Lymphocyte Function in c-ablMutant Mice. Cellular Immunology. 172(1). 100–107. 33 indexed citations
10.
Hardin, Jeff, Sharon Boast, M E Mendelsohn, Kenia de los Santos, & Steve Goff. (1996). Transgenes encoding both type I and type IV c-abl proteins rescue the lethality of c-abl mutant mice.. PubMed. 12(12). 2669–77. 16 indexed citations
11.
Hardin, Jeff, et al.. (1995). Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity. 3(1). 147–161. 455 indexed citations
12.
Hardin, Jeff, Sharon Boast, Pamela L. Schwartzberg, et al.. (1995). Bone Marrow B Lymphocyte Development in c-abl-Deficient Mice. Cellular Immunology. 165(1). 44–54. 35 indexed citations
13.
Collins, Malcolm, et al.. (1992). The abolition of collagen gene expression in SV40-transformed fibroblasts is associated with trans-acting factor switching. Nucleic Acids Research. 20(21). 5825–5830. 12 indexed citations
14.
Schwartzberg, Pamela L., Alan M. Stall, Jeff Hardin, et al.. (1991). Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations. Cell. 65(7). 1165–1175. 290 indexed citations
15.
Ramirez, Francesco, Sharon Boast, Marina D’Alessio, et al.. (1990). Fibrillar Collagen Genes. Annals of the New York Academy of Sciences. 580(1). 74–80. 10 indexed citations
16.
Boast, Sharon, Ming Su, Francesco Ramirez, Massimo Sanchez, & Enrico V. Avvedimento. (1990). Functional analysis of cis-acting DNA sequences controlling transcription of the human type I collagen genes.. Journal of Biological Chemistry. 265(22). 13351–13356. 117 indexed citations
17.
Parker, M. Iqbal, et al.. (1990). Regulation of the Human α2(I) Procollagen Gene by a Trans‐Acting Factora. Annals of the New York Academy of Sciences. 580(1). 451–453. 4 indexed citations
18.
Verde, Pasquale, Sharon Boast, Annamaria Franzè, Federico O. Robbiati, & Francesco Blasi. (1988). An upstream enhancer and a negative element in the 5' flanking region of the human urokinase plasminogen activator gene. Nucleic Acids Research. 16(22). 10699–10716. 99 indexed citations
19.
Riccio, Andrea, Giovanna Grimaldi, Pasquale Verde, et al.. (1985). The human urokinase-plasminogen activator gene and its promoter. Nucleic Acids Research. 13(8). 2759–2771. 181 indexed citations
20.
Lania, Luigi, Sharon Boast, & Mike Fried. (1982). Excision of polyoma virus genomes from chromosomal DNA by homologous recombination. Nature. 295(5847). 349–350. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026